# US 2010/0063490 A1 · Device and method for the treatment of skin, and use of the device

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2010/0063490 A1
- Document ID: US20100063490A1
- Status: Published application
- Kind: A1
- Application number: 12/305,438
- Filed: 2007-06-21
- Published: 2010-03-11
- Earliest claimed: 2006-06-26
- Assignees: Koninklijke Philips Electronics N.V.
- Inventors: Rieko Verhagen; Robbert A.M. Van Hal; Bart Gottenbos; Jozef J.M. Janssen; Paul A.J. Ackermans; Francisco Morales Serrano; Sieglinde Nerken; Dirk Brokken; Guido Roosen
- Web page: https://patentgrep.com/patent/US20100063490A1

## CPC

- A61B 18/203: {applying laser energy to the outside of the body}
- A61B 5/1077: {Measuring of profiles}
- A61B 5/442: {Evaluating skin mechanical properties, e.g. elasticity, hardness, texture, wrinkle assessment}
- A61B 18/20: using laser
- A61B 90/361: {Image-producing devices, e.g. surgical cameras}
- A61B 2017/00057: {Light}
- A61B 2017/00106: {ultrasonic}
- A61B 2017/00154: {pulsed}
- A61B 2018/00452: {Skin}
- A61B 2018/0047: {Upper parts of the skin, e.g. skin peeling or treatment of wrinkles}
- A61B 2018/00666: {using a threshold value}
- A61B 2018/00904: {Automatic detection of target tissue}
- A61B 2018/20351: {Scanning mechanisms}
- A61B 2018/20361: {with redirecting based on sensed condition, e.g. tissue analysis or tissue movement}
- A61B: DIAGNOSIS; SURGERY; IDENTIFICATION (usefulness limited to only animals A61D)

## Abstract

The invention provides a skin treatment device comprising a laser source (40) and focusing optics (50), such that a focal spot (18) is positioned in a dermis layer (24) of the skin to be treated. The laser beam (42) is powered and focused (16) such that a LIOB (laser induced optical breakdown) phenomenon is obtained, which affects the skin in order to stimulate re-growth of tissue. This in turn reduces wrinkles (30). The device may comprise wrinkle-determining means (52, 54, 56, 58). The focusing optics (50) may have a numerical aperture of at least 0.4. The invention also provides a corresponding method to treat skin, in particular to reduce wrinkles (30), by providing a focused laser beam (16) that causes LIOB in the dermis layer (24) of the skin. The advantage is that damage to overlaying epidermis layers may be avoided by the use of the very local LIOB phenomenon.

## Claims

### Claim 1

A device (10) for treatment of skin, in particular for non-invasive treatment of skin tissue, the device comprising:
a laser source (40) for generating a laser beam (42) during a predetermined pulse time, and
an optical system (46, 48, 50) for focusing the laser beam (42) into a focal spot (18),
wherein a dimension of the focal spot (18) and a power of the generated laser beam (42) are such that, in the focal spot, the laser beam has a power density which is above a characteristic threshold value for skin tissue, above which value, for the predetermined pulse time, a laser induced optical breakdown (LIOB) phenomenon occurs in the skin tissue (22, 24),
and the optical system (46, 48, 50) is arranged to position the focal spot (18), when the device (10) is applied to the skin to be treated, at a treatment depth that corresponds to a dermis layer (24) of the skin to be treated.

### Claim 2 (depends on 1)

A device according to claim 1, wherein the treatment depth is between 0.2 and 2 mm below a surface of the skin.

### Claim 3 (depends on 2)

A device according to claim 2, wherein the treatment depth is between 0.5 and 1.5 mm below the surface of the skin.

### Claim 4 (depends on 1)

A device according to claim 1, further comprising a skin surface image sensor (52, 56) that is able to determine topographical information about a surface of the skin to be treated.

### Claim 5 (depends on 4)

A device according to claim 4, wherein the skin surface image sensor (52, 56) is arranged to determine a position of a line of a locally deepest depression of the skin.

### Claim 6 (depends on 4)

A device according to claim 4, wherein the optical system (46, 48, 50) is adjustable based on the topographical information.

### Claim 7 (depends on 1)

A device according to claim 1, wherein the optical system further comprises a laser beam manipulator (46, 48) for positioning the focal spot (18).

### Claim 8 (depends on 5)

A device according to claim 5, wherein the optical system further comprises a laser beam manipulator (46, 48) for positioning the focal spot (18) with respect to said line, and in particular on or below said line.

### Claim 9 (depends on 1)

A device according to claim 1, wherein a wavelength of the laser beam (42) is between 800 and 1100 nm.

### Claim 10 (depends on 1)

A device according to claim 1, wherein the predetermined pulse time is between 100 ps and 10 ns.

### Claim 11 (depends on 1)

A device according to claim 1, wherein a deliverable energy level in the laser beam pulse is between 0.1 and 10 mJ, measured at the surface of the skin, preferably about 1 mJ.

### Claim 12 (depends on 1)

A device according to claim 1, wherein a deliverable energy level in the laser beam pulse is between 0.1 and 5 mJ, measured in a plasma generated by the LIOB phenomenon.

### Claim 13 (depends on 1)

A device according to claim 1, wherein a fluence of the laser beam pulse is at most 3 J/cm2 in an area of the skin between a surface of the skin and the dermis layer (24).

### Claim 14

A device according to any one of the preceding claims, wherein the optical system (50) has a numerical aperture of at least 0.2, preferably at least 0.4, more preferably at least 0.6.

### Claim 15

A method of treating skin, in particular non-invasive treatment of skin tissue, comprising:
providing a laser beam (42) having a laser power during a predetermined pulse time,
focusing said laser beam (42) into a focal spot (18) with a dimension such that, in the focal spot, the laser beam has a power density which is above a characteristic threshold value for skin tissue (22, 24), above which value, for the predetermined pulse time, a laser induced optical breakdown (LIOB) phenomenon occurs in the skin tissue,
wherein the focal spot (18) is positioned in a dermis layer (24) of the skin.

### Claim 16 (depends on 15)

A method according to claim 15, further comprising a step of providing a substance (62) between the skin (22, 24) to be treated and the device (10), said substance having a refractive index of between about 1.3 and 1.6, in particular about 1.4.

### Claim 17 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15)

Use of a device according to any of claims 1 to 15 in the treatment of skin, in particular non-invasive wrinkle reduction in the skin.
